Rowen Sheri L, Tooma Tom, Trieu Ngoc, Hall Brad
Nvision Eye Centers, Newport Beach, CA, USA.
Sengi, Penniac, NB, Canada.
Clin Ophthalmol. 2024 Jun 6;18:1615-1622. doi: 10.2147/OPTH.S455262. eCollection 2024.
To compare visual outcomes of eyes that had laser refractive surgery with the Contoura Phorcides treatment plan and eyes that had laser refractive surgery with the wavefront-optimized treatment plan using the same laser.
Retrospective chart review of clinical outcomes of eyes that had either Contoura with Phorcides (CP) or wavefront-optimized (WFO) corneal refractive procedures using the Wavelight EX500 (Alcon Vision, LLC). Data were collected and compared for uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), refraction, change in postoperative UDVA compared to preoperative CDVA, and change in postoperative CDVA compared to preoperative CDVA.
Total eyes included were 348, with 227 in the CP Group and 121 in the WFO Group. Post-operatively, there was a significantly higher percentage of eyes in the CP Group that were 20/16 or better compared to the WFO Group (57%, 129 eyes, and 17%, 21 eyes, respectively; p < 0.001). The percentage of eyes that gained 1 or more Snellen lines of UDVA compared to preoperative CDVA was higher in the CP Group (47%; 107 eyes) compared to the WFO Group (12%; 14 eyes), which was statistically significant (p < 0.001). Differences in refraction were statistically significant.
Topography-guided and wavefront-optimized treatment profiles both provided excellent refractive results. A higher percentage of eyes that were treated using Contoura with Phorcides achieved 20/16 or better unaided distance vision compared to eyes receiving a wavefront-optimized treatment plan.
比较采用Contoura Phorcides治疗方案接受激光屈光手术的眼睛与采用波前优化治疗方案并使用同一台激光设备接受激光屈光手术的眼睛的视觉效果。
回顾性分析使用威视EX500(爱尔康视力公司)进行Contoura联合Phorcides(CP)或波前优化(WFO)角膜屈光手术的眼睛的临床结果。收集并比较未矫正远视力(UDVA)、矫正远视力(CDVA)、屈光不正、术后UDVA相对于术前CDVA的变化以及术后CDVA相对于术前CDVA的变化。
纳入的眼睛总数为348只,CP组227只,WFO组121只。术后,CP组中视力达到20/16及以上的眼睛百分比显著高于WFO组(分别为57%,129只眼和17%,21只眼;p<0.001)。与术前CDVA相比,UDVA提高了1行或更多Snellen行的眼睛百分比,CP组(47%;107只眼)高于WFO组(12%;14只眼),差异具有统计学意义(p<0.001)。屈光不正的差异具有统计学意义。
地形图引导和波前优化治疗方案均提供了出色的屈光效果。与接受波前优化治疗方案的眼睛相比,采用Contoura联合Phorcides治疗的眼睛中,有更高百分比的眼睛实现了20/16或更好的裸眼远视力。